ClinConnect ClinConnect Logo
Search / Trial NCT01728597

Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols

Launched by MEDICAL UNIVERSITY OF GRAZ · Nov 13, 2012

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

No History Of Cardiovascular Diseases

ClinConnect Summary

This clinical trial is studying how to improve and standardize cardiac magnetic resonance (MR) imaging techniques without using contrast agents, which are substances usually injected to enhance image quality. Researchers are looking to gather normal values for different heart imaging methods, focusing on how the heart looks and functions, including its size, blood flow, and the condition of the coronary arteries. This research will help ensure that cardiac MR images are accurate and reliable for diagnosing heart conditions in the future.

To participate in the trial, individuals must be between the ages of 65 and 74 and have no history of heart or lung diseases. They should also be able to give consent to participate. However, people with certain metal implants, those who are pregnant, or those who experience severe anxiety in confined spaces (claustrophobia) cannot take part. If eligible, participants can expect to undergo non-invasive MR imaging procedures, which are safe and painless, helping advance the understanding of heart health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • No history of cardiac or pulmonary diseases
  • ability to give informed consent
  • Exclusion Criteria:
  • General MR exclusion criteria eg. patients with metal devices or other magnetic material in or on the subjects body which will be hazardous for MR investigation (e.g. heart pace-maker, brain aneurysm clip, nerve stimulators, electrodes, penile implants, coloured contact lenses, patch to deliver medications through the skin, any metal implants as rods, joints, plates, pins, screws, nails or clips, embolization coil, or any metal fragments or shrapnel in the body),
  • pregnancy,
  • claustrophobia.

About Medical University Of Graz

The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.

Locations

Graz, Styria, Austria

Patients applied

0 patients applied

Trial Officials

Ursula Reiter, PhD

Principal Investigator

Medical Unitersity Graz, Department of Radiology, Division of General Radiology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials